Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria.

Protecting against both liver and blood stages of infection is a long-sought goal of malaria vaccine design. Recently, we described the use of replication-defective viral vaccine vectors expressing the malaria antigen merozoite surface protein-1 (MSP-1) as an antimalarial vaccine strategy that elici...

詳細記述

書誌詳細
主要な著者: Draper, S, Goodman, A, Biswas, S, Forbes, E, Moore, A, Gilbert, S, Hill, A
フォーマット: Journal article
言語:English
出版事項: 2009